CAS: 158407-04-6; Tert-Butyl 4-(Bromomethyl)Piperidine-1-Carboxylate

该化合物是一种化合物,其特点是其管状环结构,即六人组成的含氮的乙基环循环,其存在表明一种与管道氮相邻的甲基群体相连的溴原子,增强了其反应性和进一步化学改造的潜力;异丁基酯功能组表示,盒状酸混合物已经用一种可影响化合物溶解性和稳定性的异丁基化合物组来消化;该化合物通常用于有机合成和药用化学,通常作为制造更为复杂的分子的中间体;其特性,如沸点,熔点和溶性,可根据具体条件和其他功能组的存在而变化;在处理时,应参考安全数据,因为溴原子可产生毒性和再活性.

结构式图片

相似化合物

1159825-22-5 159275-17-9 98338-26-2

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号123855-51-6 N-B°C-4-哌啶甲醇 | CAS号498-94-2 4-哌啶甲酸 | CAS号24424-99-5 二碳酸二叔丁酯 | CAS号84358-13-4 1-B°C-4-哌啶甲酸 | CAS号145508-94-7 1-叔丁氧羰基-4-碘甲基哌啶

合成工艺路线路线简述

  • 合成目标产物 4-Bromomethypiperidine-1-Carboxylic Acid Tert-Butyl Ester 主要起始原料 N-Boc-4-Piperidinemethanol
  • (文献来源)合成步骤主要原料 N-Boc-4-Piperidinemethanol
📜4-哌啶甲醇置于三苯基膦,Sodium Hydroxide体系中,用 1,4-二氧六环,二氯甲烷,水 用作溶剂,化学反应 1.58H,反应生成1-Boc-4-溴甲基哌啶
参考文献:一类具有tdo,Ido1双重抑制活性的化合物及制备治疗神经退行性疾病药物的用途
标题:一类具有tdo,Ido1双重抑制活性的化合物及制备治疗神经退行性疾病药物的用途
摘要:本发明提供了式i所示的化合物,或其药学上可接受的盐,或其溶剂合物,其可以选择性地抑制tdo,Ido1,其对tdo和/或ido1具有明显的抑制效果.此外,本发明制备的化合物具有明显的抗肿瘤效果,对帕金森病,阿尔茨海默症也有一定治疗作用,其在药物制备领域具有很好的应用前景.

海关参考信息

专利信息


专利号:US-12441733-B2
优先权日:2018-03-26
标题:Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitors
发明人:ARISTA LUCA; HEBACH CHRISTINA; HOLLINGWORTH GREGORY JOHN; HOLZER PHILIPP; IMBACH-WEESE PATRICIA; LORBER JULIEN; MACHAUER RAINER; SCHMIEDEBERG NIKO; VULPETTI ANNA; ZOLLER THOMAS
权利人:NOVARTIS AG
摘要:The invention relates to compounds of the formulae (I), (III), (IIIa), (XXIa), (XXIII), and/or (XLVI)or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.

专利号:US-9249154-B2
优先权日:2008-01-08
标题:Compounds and therapeutic use thereof for protein kinase inhibition
发明人:WU ZHANGGUI
权利人:WU ZHANGGUI
摘要:Novel compound having the following formula: n nAlso disclosed are a pharmaceutical compositions comprising the same, methods for treating cancer using the same, and methods for the synthesis of the same. The novel compounds of the present invention are found to inhibit protein kinases, especially Checkpoint kinase Chk1/Chk2.

专利号:US-9925177-B2
优先权日:2015-01-22
标题:4-methylsulfonyl-substituted piperidine urea compounds
发明人:OSLOB JOHAN; AUBELE DANIELLE; KIM JAE; MCDOWELL ROBERT; SONG YONGHONG; SRAN ARVINDER; ZHONG MIN
权利人:MYOKARDIA INC
摘要:The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of the compounds is described, as well as methods for treating DCM and other forms of heart disease.

专利号:US-11123337-B2
优先权日:2015-01-22
标题 :4-methylsulfonyl-substituted piperidine urea compounds
发明人:OSLOB JOHAN; AUBELE DANIELLE; KIM JAE; MCDOWELL ROBERT; SONG YONGHONG; SRAN ARVINDER; ZHONG MIN
权利人:MYOKARDIA INC
摘要:The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of the compounds is described, as well as methods for treating DCM and other forms of heart disease.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Wang, X.; Lu, X., Science of Synthesis: DNA-Encoded Libraries, (2024) nan, 243.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知